Global Primary Cells Market to Grow at a CAGR of 11.4% During 2024-2032, Aided by the Utilisation of Primary Cells to Produce Vaccinations

North America is expected to hold a significant share in the overall market growth of primary cells. This can be attributed to the increasing applications of primary cells in the stem cell therapy for tissue regeneration for the treatment of cancers, spinal cord injuries, and other immunodeficiency disorders. In addition to this, the growth in the region is majorly driven by huge investments into research and development (R&D) and the growth of the healthcare sector in the region. Moreover, the growth in the regional market can also be attributed to the presence of leading biopharmaceutical companies in the region, which effectively utilise primary human and animal cells for the production of vaccines against diseases like rabies, chickenpox, and polio, among others. Further, the COVID-19 pandemic also accelerated the pharmaceutical and biotechnology-based research projects, which also included the development of cell therapy driven by primary cells, hence further stimulating the market growth in the region.

In March 2021, Axol Bioscience Ltd., a global leader in the market for primary cells, recently announced a merger with Censo Biotechnologies. The merged company is focused on providing product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery and screening markets. Further, it will offer validated ready-to-use cell lines to its customers along with expert services, robust functional data, and customisation capabilities in short time. Such expansion projects undertaken by leading market players are augmenting the overall market for primary cells. The market is further augmented by the developments made by the leading players in the market, including Lonza Group AG. (SWX: LONN).

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Origin, Cell Type, End User, and Region:

• On the basis of origin, the market can be divided into animal primary cells and human primary cells.

• The market, based on cell type, can be broadly categorised into dermatocytes, gastrointestinal cells, heart cells, hematopoietic cells, hepatocytes, lung cells, musculoskeletal cells, and renal cells, among others.

• Based on end user, the market can be segmented into life science research companies and research institutes.

• The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The global market for primary cells is being driven by the rising investments into research and development (R&D) for the development of novel techniques to treat cancers.

• Advancements in biotechnology and biopharmaceutical sector is leading to the advancements of cell therapies and regenerative therapies, which is invigorating the market growth of primary cells.

• Primary cells are utilised for the discovery of cancer cells and drug screening owing to effectiveness over cell lines, hence bolstering the overall market growth.

• Effective use of animal and human-based primary cells for the production of vaccinations to cure diseases like rabies, chickenpox, and polio, among others, by leading players, is augmenting the market growth of primary cells.

Key Offerings of the Report:

• The EMR report gives an overview of the global primary cells industry for the periods (2018-2023) and (2024-2032).

• The report also offers historical (2018-2023) and forecast (2024-2032) markets for origins, cell types, end users, and regions of primary cells. 

• The report analyses market dynamics, covering the key demand and price indicators in the market along with an assessment of the SWOT and Porter’s Five Forces Model.

The major players in the global primary cells market are Merck KGaA, Axol Bioscience Ltd., Cell Biologics, Inc., Lonza Group AG., and PromoCell GmbH, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.